DexCom faces challenges in 2024 due to competition and missteps, but the long-term outlook for continuous glucose monitors ...
The CGM market is practically a duopoly that DexCom shares with Abbott Laboratories. DexCom's success in this market explains ...
The Unified Patent Court in Paris sided with Abbott (NYSE:ABT) following a CGM patent infringement claim from Dexcom ...
CNN on MSN10d
I don’t have diabetes, but I wore a glucose monitor for six weeks. Here’s what I learned about food (and anxiety)One day in September, I stood in front of my open refrigerator, ravenous but unable to figure out what I should eat.
In a report released today, Larry Biegelsen from Wells Fargo maintained a Buy rating on Dexcom (DXCM – Research Report), with a price target of ...
In the assessment of 12-month price targets, analysts unveil insights for DexCom, presenting an average target of $98.44, a ...
Oura has become incredibly popular in the last few years. The company, originally from Finland, launched its first wearable ...
The American Diabetes Association has released its annual guidelines and they now include continuous glucose monitor use for non-insulin use, ...
Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. today announced that following the recent authorization of sale by ...
Tandem Diabetes Care has received authorization of sale by Health Canada, paving the way for in-warranty t:slim X2 insulin pump users to be full compatibility with both the Dexcom G7 and Dexcom G6 ...
Let's consider three of them. DexCom is a leader in the continuous glucose monitoring (CGM) systems market. They aren't the only kinds of devices that help diabetes patients keep track of their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback